Hemolysis Treatments
Find Hemolysis Treatments
Medications for Hemolysis
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hemolysis.
Found 1 Approved Drug for Hemolysis
Enjaymo
Generic Name
Sutimlimab-Jome
Enjaymo
Generic Name
Sutimlimab-Jome
Form: Injection
Method of administration: Intravenous
FDA approval date: February 04, 2022
Classification: Classical Complement Pathway Inhibitor
ENJAYMO is a classical complement inhibitor indicated for the treatment of hemolysis in adults with cold agglutinin disease (CAD). ( 1 ) Cold Agglutinin Disease ENJAYMO (sutimlimab-jome) is indicated for the treatment of hemolysis in adults with cold agglutinin disease (CAD).
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances